| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3347722 | Diagnostic Microbiology and Infectious Disease | 2009 | 4 Pages |
Abstract
A review of 12 patients with proven Aspergillus osteomyelitis was undertaken between July 2004 and October 2007. Aspergillus fumigatus was most commonly identified (n = 9). Voriconazole was commonly administered (11/12; 91.7%), and 9 (75.0%) underwent surgery. Seven (58.3%) responded to treatment, and 12-week mortality was 25.0% (3/12). Survival was improved with surgical intervention (P = 0.05).
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
David Horn, Sutthichai Sae-Tia, Dionissios Neofytos,